You just read:

Takeda's Vedolizumab Demonstrated Robust Clinical Effectiveness and Safety in Inflammatory Bowel Disease in More Than 50 Real-World Studies

News provided by

Takeda Pharmaceutical Company Limited

Oct 17, 2016, 02:00 ET